Investor Centre

0.009
UN
CH.
0.00
(0.00)
3:39PM 29/6 (NZST)
VOLUME
554477
52 WEEK RANGE
0.0045 - 0.019
1 YR RETURN
-100
Key Information

MARKET CAPITALISATION

$11568240

Novel therapies for serious diseases

LCT is an Australasian biotechnology company improving the wellbeing of people with serious diseases by discovering, developing and commercialising novel treatments for debilitating conditions such as Parkinson’s disease, obesity and migraine.

Our product candidates leverage the potential of cells and their receptors to address serious conditions that have an unmet need for effective treatments.

We are listed on both the Australian Securities Exchange (ASX:LCT) and the international OTCQB (LVCLY). Share registry services are provided by Computershare.